Pro Dex Ownership
PDEX Stock | USD 46.75 4.42 10.44% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 4 M | Current Value 3 M | Avarage Shares Outstanding 3.6 M | Quarterly Volatility 485.3 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Pro |
Pro Stock Ownership Analysis
About 36.0% of the company outstanding shares are owned by corporate insiders. The book value of Pro Dex was at this time reported as 9.36. The company had not issued any dividends in recent years. Pro Dex had 1:3 split on the 18th of June 2010. Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company was founded in 1978 and is headquartered in Irvine, California. Pro Dex operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. To find out more about Pro Dex contact Richard Kirk at 949 769 3200 or learn more at https://www.pro-dex.com.Besides selling stocks to institutional investors, Pro Dex also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Pro Dex's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Pro Dex's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Pro Dex Quarterly Liabilities And Stockholders Equity |
|
Pro Dex Insider Trades History
About 36.0% of Pro Dex are currently held by insiders. Unlike Pro Dex's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Pro Dex's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Pro Dex's insider trades
Pro Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Pro Dex is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pro Dex backward and forwards among themselves. Pro Dex's institutional investor refers to the entity that pools money to purchase Pro Dex's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Advisor Group Holdings, Inc. | 2024-06-30 | 11.5 K | State Street Corp | 2024-06-30 | 10.6 K | Perritt Capital Management Inc. | 2024-09-30 | 6 K | Fmr Inc | 2024-09-30 | 4 K | Ubs Group Ag | 2024-06-30 | 3.6 K | Global Retirement Partners, Llc. | 2024-09-30 | 1000 | Tower Research Capital Llc | 2024-06-30 | 543 | Goss Wealth Management Llc | 2024-06-30 | 416 | Northwestern Mutual Wealth Management Co | 2024-06-30 | 263 | Vanguard Group Inc | 2024-09-30 | 121.1 K | Punch & Associates Inv Mgmt Inc | 2024-09-30 | 68 K |
Pro Dex Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pro Dex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pro Dex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pro Dex insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pro Dex Outstanding Bonds
Pro Dex issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pro Dex uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pro bonds can be classified according to their maturity, which is the date when Pro Dex has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
PRIVATE EXPT FDG Corp BondUS742651DW99 | View |
Pro Dex Corporate Filings
8K | 22nd of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 8th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8th of October 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pro Stock Analysis
When running Pro Dex's price analysis, check to measure Pro Dex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Dex is operating at the current time. Most of Pro Dex's value examination focuses on studying past and present price action to predict the probability of Pro Dex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Dex's price. Additionally, you may evaluate how the addition of Pro Dex to your portfolios can decrease your overall portfolio volatility.